Medison Pharma

Medison Pharma company information, Employees & Contact Information

Explore related pages

Related company profiles:

Medison is redefining global biotech commercialization to change lives. As the first of its kind unified global commercialization platform, Medison partners with biotech companies to bring breakthrough therapies to patients worldwide, especially those with severe and rare diseases. We specialize in accelerating access and expanding reach in markets beyond the U.S., Western Europe, and Japan. Our unique affiliate-like model seamlessly integrates commercial, medical, and operational capabilities across diverse regions, enabling biotech innovators to scale globally without compromising on local impact. By applying creativity, expertise, passion, and a borderless mindset, we’re accelerating access to breakthrough therapies, bringing hope to more lives in more places. We strongly believe that every patient deserves the same chance to a full life, no matter where they live, and we are here to make that belief a reality.

Company Details

Employees
689
Founded
-
Address
10 Hashiloach Street, Petach Tikva,4917002,israel
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Petach Tikva
Looking for a particular Medison Pharma employee's phone or email?

Medison Pharma Questions

News

Victor Papamoniodis Joins Medison Pharma as VP International Markets - PR Newswire

Victor Papamoniodis Joins Medison Pharma as VP International Markets PR Newswire

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia - BioSpace

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia BioSpace

Carla Madison Recreation Center - City and County of Denver - City and County of Denver

Carla Madison Recreation Center - City and County of Denver City and County of Denver

Moderna and Medison Pharma partner to commercialize Moderna's COVID-19 vaccine across Central Eastern Europe and Israel - PR Newswire

Moderna and Medison Pharma partner to commercialize Moderna's COVID-19 vaccine across Central Eastern Europe and Israel PR Newswire

Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia - PR Newswire

Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia PR Newswire

BridgeBio Pharma, Sentynl Therapeutics and Medison Pharma Announce Approval in Israel for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A - PR Newswire

BridgeBio Pharma, Sentynl Therapeutics and Medison Pharma Announce Approval in Israel for NULIBRY® (fosdenopterin) for the Treatment of MoCD Type A PR Newswire

Medison Pharma Announces Multi-Regional Partnership Agreement with argenx to Commercialize Efgartigimod Across Europe and Israel - PR Newswire

Medison Pharma Announces Multi-Regional Partnership Agreement with argenx to Commercialize Efgartigimod Across Europe and Israel PR Newswire

Medison Pharma Enters Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize QINLOCK® (Ripretinib) in a Multi-Regional Agreement - PR Newswire

Medison Pharma Enters Exclusive Distribution Agreement with Deciphera Pharmaceuticals to Commercialize QINLOCK® (Ripretinib) in a Multi-Regional Agreement PR Newswire

Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel - PR Newswire

Medison Pharma Announces the Expansion of its Partnership with Albireo to a Multi-Regional Agreement to Commercialize Odevixibat in Canada and Israel PR Newswire

Biohaven Enters Into Partnership With Medison Pharma To Distribute NURTEC™ ODT In Israel - PR Newswire

Biohaven Enters Into Partnership With Medison Pharma To Distribute NURTEC™ ODT In Israel PR Newswire

Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries - PR Newswire

Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries PR Newswire

Sarah Otten Joins Medison Pharma as VP, GM Americas Region - PR Newswire

Sarah Otten Joins Medison Pharma as VP, GM Americas Region PR Newswire

Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics - PR Newswire

Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics PR Newswire

Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand - PR Newswire

Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand PR Newswire

Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America - PR Newswire

Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America PR Newswire

Medison Pharma and Alpha Tau Medical Announce a Collaboration in the Oncology Field in Central and Eastern Europe - PR Newswire

Medison Pharma and Alpha Tau Medical Announce a Collaboration in the Oncology Field in Central and Eastern Europe PR Newswire

Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment - PR Newswire

Medison Pharma Announces Public Formulary Listing of QINLOCK® (ripretinib) in Canadian Provinces: Ontario and Quebec for Advanced Gastrointestinal Stromal Tumor (GIST) Treatment PR Newswire

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC) - PR Newswire

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC) PR Newswire

Samsung Medison to buy AI ultrasound company Sonio - medtechdive.com

Samsung Medison to buy AI ultrasound company Sonio medtechdive.com

Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer - PR Newswire UK

Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer PR Newswire UK

Gentium Signs License and Distribution Agreement for Defibrotide With Medison Pharma Ltd. in Israel and the Palestinian Authority - NBC News

Gentium Signs License and Distribution Agreement for Defibrotide With Medison Pharma Ltd. in Israel and the Palestinian Authority NBC News

Samsung Medison concludes acquisition of French AI startup Sonio - 매일경제

Samsung Medison concludes acquisition of French AI startup Sonio 매일경제

Oncology Company Alpha Tau Raises $29 Million - CTech

Oncology Company Alpha Tau Raises $29 Million CTech

BDMS and Samsung Medison sign MoU for medical advancements - Healthcare Asia Magazine

BDMS and Samsung Medison sign MoU for medical advancements Healthcare Asia Magazine

Samsung Medison completes acquisition of French AI ultrasound firm Sonio - Express Healthcare

Samsung Medison completes acquisition of French AI ultrasound firm Sonio Express Healthcare

Medison Biotech launching fight for control of Knight Therapeutics, following year-long activist campaign against CEO Jonathan Goodman - The Globe and Mail

Medison Biotech launching fight for control of Knight Therapeutics, following year-long activist campaign against CEO Jonathan Goodman The Globe and Mail

Disney fund Shamrock invests in Medison Pharma - Globes - Israel Business News

Disney fund Shamrock invests in Medison Pharma Globes - Israel Business News

Top Medison Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant